Clinical Trial

IPACK on Early Pain Scores After ACL Reconstruction

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2023 (before its estimated August 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn whether using an anesthetic technique called IPACK block will control pain after ACL reconstruction surgery. The main questions it aims to answer are: * if participants who receive the IPACK block prior to ACL reconstruction experience less pain after surgery and at 1 day after surgery * if participants who receive the IPACK block prior to ACL reconstruction require less short-term opioid use immediately after surgery and up to one week after surgery. Participants will be randomized 1:1 to 1 of 2 groups: Use of IPACK block during ACL reconstruction vs. placebo (a placebo is a look-alike substance that contains no active drug). Neither the participant nor the investigator will know which group the participants has been assigned to. Researchers will compare self-reported pain scores and short-term opioid use of all study participants.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05985629
Lead Sponsor Loyola University
Conditions Pain, Postoperative, Anterior Cruciate Ligament Injuries, Analgesics, Opioid
Enrollment 78 participants
Start Date 2023-08-03
Primary Completion 2025-08-03 (estimated)
Study Completion 2026-08-03 (estimated)
Updated on ClinicalTrials.gov 2023-08-14